Theravance Biopharma
Theravance Biopharma develops inhalation therapies for respiratory diseases.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 9Latest story
September 2026
August 2026
June 2026
Theravance Biopharma develops inhalation therapies for respiratory diseases.
September 2026
August 2026
June 2026